Amid efficacy row, Indian Covid19 Vaccine gets thumbs-up from Lancet

India's first home-made vaccine against Covid-19 led to tolerable safety outcomes and enhanced immune responses without much serious side effects in the Phase 1 trials, the results published in UK's scientific journal Lancet Infectious Disease journal show.